- Home
- TNGX vs URG Comparison
TNGX vs URG Comparison
Compare TNGX & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- URG
- Stock Information
- Founded
- TNGX 2014
- URG 2004
- Country
- TNGX United States
- URG United States
- Employees
- TNGX N/A
- URG N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- URG Precious Metals
- Sector
- TNGX Health Care
- URG Basic Materials
- Exchange
- TNGX Nasdaq
- URG Nasdaq
- Market Cap
- TNGX 351.2M
- URG 339.5M
- IPO Year
- TNGX N/A
- URG N/A
- Fundamental
- Price
- TNGX $5.16
- URG $1.06
- Analyst Decision
- TNGX Strong Buy
- URG Strong Buy
- Analyst Count
- TNGX 6
- URG 2
- Target Price
- TNGX $12.20
- URG $2.45
- AVG Volume (30 Days)
- TNGX 3.9M
- URG 8.5M
- Earning Date
- TNGX 08-06-2025
- URG 08-08-2025
- Dividend Yield
- TNGX N/A
- URG N/A
- EPS Growth
- TNGX N/A
- URG N/A
- EPS
- TNGX N/A
- URG N/A
- Revenue
- TNGX $40,990,000.00
- URG $33,706,000.00
- Revenue This Year
- TNGX N/A
- URG N/A
- Revenue Next Year
- TNGX N/A
- URG $251.38
- P/E Ratio
- TNGX N/A
- URG N/A
- Revenue Growth
- TNGX 10.09
- URG 200.09
- 52 Week Low
- TNGX $1.03
- URG $0.55
- 52 Week High
- TNGX $12.02
- URG $1.53
- Technical
- Relative Strength Index (RSI)
- TNGX 79.99
- URG 65.53
- Support Level
- TNGX $4.40
- URG $0.90
- Resistance Level
- TNGX $5.37
- URG $1.14
- Average True Range (ATR)
- TNGX 0.65
- URG 0.08
- MACD
- TNGX 0.10
- URG 0.02
- Stochastic Oscillator
- TNGX 93.68
- URG 82.48
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.